Market Tracker

09/23 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

27.28
Delayed Data
As of Sep 23
 +0.06 / +0.22%
Today’s Change
23.59
Today|||52-Week Range
43.63
-36.23%
Year-to-Date
No recent news for Acorda Therapeutics Inc.

Today’s Trading

Previous close27.22
Today’s open27.24
Day’s range27.02 - 27.62
Volume537,126
Average volume (3 months)523,746
Market cap$1.3B
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-59.26%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.94

Competitors

 Today’s
change
Today’s
% change
TXMDTherapeuticsMD Inc+0.15+2.40%
INVAInnoviva Inc+0.01+0.09%
SUPNSupernus Pharmaceuti...+0.15+0.58%
PTLAPortola Pharmaceutic...-0.52-2.19%
Data as of 4:00pm ET, 09/23/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Head-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts